Login Get Started
Browse
Shares
Healthcare
Biotechnology & Medical Research
Chromadex
Chromadex logo

CDXC - Chromadex Share News

$9.74 0.2  2.1%

Last Trade - 9:00pm

Sector
Healthcare
RiskRating
Adventurous
Size
Mid Cap
Style
High Flyer
Market Cap £417.8m
Enterprise Value £406.9m
Revenue £40.3m
Position in Universe 3313th / 6714
Quality
Value
Momentum
StockRank™
StockReport™
Tools
Compare with... Run through checklist
Accounts
Balance sheet Income statement Cashflow statement Dividend summary
Charts News Discussions CDXC Dividends
All News
All News Reuters News Company Announcements
BRIEF-New Phase 3 Clinical Study Finds Nutritional Protocol Including Nicotinamide Riboside Accelerates Recovery In Mild-To-Moderate Covid-19 Patients
11:41am News
BRIEF-Chromadex Announces $25 Million Private Placement Of Common Stock
Mon 11:38am News
BRIEF-Chromadex Corp - Received A Warning Letter From FDA And FTC On Nov 17
23rd Nov '20 News
BRIEF-Chromadex Announces New Clinical Trial To Investigate Niagen And Milk Production Among Mothers In The Neonatal Intensive Care Unit
17th Nov '20 News
BRIEF-Chromadex And Watsons Launch New Tru Niagen Ex Stick Packs In Hong Kong Expanding Product Line And Advancing Global Retail Partnership
9th Nov '20 News
BRIEF-Chromadex Corporation Reports Third Quarter 2020 Financial Results
4th Nov '20 News
BRIEF-Chromadex Says Study In Nature Immunology Found That Nicotinamide Riboside Improved AntiCancer Function Of Tumor Infiltrating Immune TCells In Mice
8th Oct '20 News
BUZZ-U.S. STOCKS ON THE MOVE-Facebook, Amazon.com, Nvidia
6th Oct '20 News
BUZZ-U.S. STOCKS ON THE MOVE-Facebook, Amazon.com, Nvidia
6th Oct '20 News
BUZZ-U.S. STOCKS ON THE MOVE-Norwegian Cruise Line, Charles Schwab, Social Capital Hedosophia, Farmmi
6th Oct '20 News
BUZZ-U.S. STOCKS ON THE MOVE-Conformis, Oragenics, Himax Technologies, Gamida Cell, Leaf Group
6th Oct '20 News
BUZZ-Chromadex: Up after co's supplement reduces recovery time in COVID-19 patients
6th Oct '20 News
BRIEF-New Preclinical Study Finds Niagen Prevents Light-Induced Retinal Damage In Mice
9th Sep '20 News
BRIEF-New Pilot Study Indicates Niagen® May Reduce Inflammatory Cytokines In Heart Failure Patients
18th Aug '20 News
BRIEF-Chromadex Corporation Reports Second Quarter 2020 Financial Results
6th Aug '20 News
BRIEF-Chromadex Reports New Study Finds Niagen Corrects Social Deficits In Mouse Model Of Autism
16th Jul '20 News
BRIEF-Chromadex Signed 200th Material Transfer Agreement Through Its Global Chromadex External Research Program
14th Jul '20 News
BRIEF-Chromadex And NIH-NIAID Rocky Mountain Laboratories Announce Study To Assess Therapeutic Potential Of Niagen® In Covid-19 Animal Models
7th Jul '20 News
BRIEF-Chromadex Says May Offer & Sell Shares Of Common Stock Of Up To $50 Mln From Time To Time, Pursuant To Sales Agreement, Dated June 12, 2020
26th Jun '20 News
BRIEF-ChromaDex Says An R&D Facility In Colorado Earns Accredition
17th Jun '20 News
© Stockopedia 2021, Refinitiv, Share Data Services.
Youtube Instagram RSS
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.